Clinical Significance
CD160 as a potential new target in cases of human pathological ocular and tumor neoangiogenesis that do not respond or become resistant to existing antiangiogenic drugs.
Additional anti-CD160 antibody therapeutics under development (preclinical trials in 2011-13) developed by Orega Biotech in Lyon, France.
Read more about this topic: CD160
Famous quotes containing the word significance:
“I am not afraid that I shall exaggerate the value and significance of life, but that I shall not be up to the occasion which it is.”
—Henry David Thoreau (1817–1862)